CRNX: Crinetics Pharmaceuticals Inc

CRNX Notícias

• Investing 09:21 JMP reiterates Market Outperform rating on Crinetics stock as paltusotine shows strong data
• Benzinga 18:18 Crinetics Reports Durable Symptom, Hormone Control With Oral Drug In Acromegaly - Crinetics Pharmaceuticals (NASDAQ:CRNX)
• Investing 10:08 Goldman Sachs initiates coverage on Crinetics stock with Neutral rating
• Investing 18:01 Alibaba, Merck Stir Wednesday’s Market Cap Stock Movers
• Investing 08:55 Crinetics stock rating reiterated at Market Outperform by JMP ahead of key data
• Investing 11:41 H.C. Wainwright reiterates buy rating on Crinetics stock at $81 target
• Investing 12:12 Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025
• Seeking Alpha 07:54 Crinetics: Highly Priced Biotech Awaits PDUFA On Acromegaly Drug (NASDAQ:CRNX)
• Seeking Alpha 14:10 PGIM Jennison Health Sciences Fund Q1 2025 Commentary (PHLAX)
• Investing 20:44 Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• Investing 11:32 H.C. Wainwright maintains Crinetics stock Buy rating, $81 target
• Investing 12:12 Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025
• Investing 20:16 Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting  2025
• Seeking Alpha 18:15 Crinetics Pharma: Strong Progress With Indications And Upcoming PDUFA (NASDAQ:CRNX)
• Benzinga 19:56 JP Morgan Survey: 90% Of Endocrinologists Are Aware Of Crinetics' Atumelnant Data - Crinetics Pharmaceuticals (NASDAQ:CRNX)
• Benzinga 18:49 Crinetics Pharmaceuticals Analyst Sees Around 70% Upside For Stock, Cites More Investor Interest In Endocrinology - Crinetics Pharmaceuticals (NASDAQ:CRNX)
• Benzinga 14:50 This Clearway Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Avalo Therapeutics (NASDAQ:AVTX), Assembly Biosciences (NASDAQ:ASMB)